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Effect of oral administration of green tea extract in various 
dosage schemes on oxidative stress status of mice in vivo
Green tea is a favorite beverage and its extracts are popular 
components of dietary supplements. The aim of the present 
in vivo study was to obtain detailed information about the 
effect of a standard green tea extract (Polyphenon, P), at 
different doses, on antioxidant enzymes and oxidative 
stress markers in murine blood, liver, small and large intes-
tine. In all doses, P improved the oxidative stress status via 
an increased content of plasmatic SH-groups (by 21–67 %). 
Regarding antioxidant enzymes in tissues, the low dose of 
P had the best positive effect as it elevated the activity of 
NADPH quinone reductase in liver and small intestine, 
thioredoxin reductase in small intestine and hepatic super-
oxide dismutase. Based on these facts, consumption of 
green tea seems to be safe and beneficial, while consump-
tion of dietary supplements containing high doses of cate-
chins may disturb oxidative balance by lowering the activ-
ity of thioredoxin reductase, glutathione S-transferase, 
glutathione reductase and superoxide dismutase.
Keywords: green tea extract, dietary supplement; flavo-
noids, green tea catechins, antioxidant enzymes
Aerobic organisms possess antioxidant defense systems that can cope with reactive 
oxygen species (ROS), including hydroxyl radicals, superoxide radicals and hydrogen per-
oxide. This defense system consists of antioxidant enzymes and low molecular mass sub-
stances capable of ROS scavenging (1). The most important antioxidant enzymes are su-
peroxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), glutathione 
S-transferase (GST), NAD(P)H quinone reductase (NQO), thioredoxin reductase (TrxR) 
and glutathione reductase (GR), which ensures proper GPx function. Antioxidant sub-
stances include vitamins C and E, thiol compounds and phytonutrients such as carot-
enoids or flavonoids (1).
Green tea catechins (i.e., epicatechin, epigallocatechin, epicatechin gallate, and epigal-
locatechin gallate), representing a class of flavonoids, show protective qualities against a 
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obesity (2). Ample evidence of their benefi cial eff ects on human health has led to the in-
creasing popularity of food supplements, which contain catechins in high doses (3). It is 
therefore essential to keep in mind the possible undesired eff ects the catechins – such as 
toxicity (4), pro-oxidative eff ects (4) or alteration of drug-metabolizing enzymes and trans-
porters (2, 5). On the other hand, the modulation of detoxifying enzymes by catechins can 
contribute to chemoprotection and antioxidant defense of organisms (6).
The eff ects of green tea catechins on oxidative stress and antioxidant enzymes de-
scribed in the literature are inconsistent. Whereas some studies documented signifi cant 
induction of antioxidant enzymes (e.g., NQO, GPx, CAT, SOD) via green tea catechins (6), 
another study showed a decrease in NQO and no changes of other antioxidant enzymes 
in catechin-treated rats (7). Evaluation of published reports is complicated and their com-
parison almost impossible due to totally diff erent experimental conditions (diff erences, 
e.g., in animal species and strains, administered substances, dosage schemes, and route of 
administration). Moreover, most of the studies were focused only on one tissue (mostly 
blood or liver) and a complex view was lacking.
Therefore, the present in vivo study was designed to test the eff ect of green tea extract 
(in three diff erent dosage schemes) on oxidative stress parameters and the activity of a 
panel of antioxidant enzymes in liver, erythrocytes, small and large intestine in mice to 
obtain more complex information. Polyphenon, the defi ned and commercially available 
form of green tea extract, was used in this study.
EXPERIMENTAL
Chemicals and reagents
Protease inhibitor cocktail tablets (EDTA free complete protease inhibitor cocktail 
tablets) were supplied by Roche (Switzerland). SOD assay kit-WST [2-(4-iodo phenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt] was provided by 
Dojindo (Japan). Polyphenon 60 was a product of Sigma-Aldrich (Czech Republic). Protein 
standard for electrophoresis was obtained from Bio-Rad (USA). All other chemicals, which 
were of HPLC or analytical grade, were obtained from Sigma-Aldrich. The GST and β-actin 
antibodies were purchased from Abcam (UK). The NQO primary and secondary antibo-
dies were supplied by Novus Biologicals (UK) and Santa Cruz Biotechnology (USA). West-
ern blo ing was done using a chemiluminescence kit from Santa Cruz Biotechnology 
(USA).
Polyphenon 60 was a product of Sigma-Aldrich (Czech Republic). Based on HPLC 
analysis (8) performed by our research group, the content of individual catechins in Poly-
phenon 60 was as follows: (–)-epicatechin 12.5 %, (–)-epigallocatechin 32.7 %, (–)-epigalo-
catechin gallate 41.8 %, and (–)-epicatechin gallate 13.0 % of the total catechins, amounting 
to 100 % (8).
Experimental animals
Male NMRI mice obtained from Medi Tox (Konárovice, Czech Republic) were housed 
at a temperature of 23 °C and a daily light and dark cycle of 12 h (light from 6:00 a.m.). 
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Animals were given water ad libitum and a standard chow diet (ST-1, Velaz, Czech Repub-
lic). They were cared for and used in accordance with the Guide for the Care and Use of 
Laboratory Animals (Protection of Animals from Misuse Act No. 246/92, Czech Republic). 
The Ethical Commi ee of Charles University in Prague, Faculty of Pharmacy in Hradec 
Králové, approved all animal experimental procedures.
At 7 months of age, mice were randomly divided into 4 groups (12 mice per group). 
For further 4 weeks (28 days), the fi rst group (control) was fed a standard diet without 
Polyphenon (P), the second group (P-H28) was fed a 0.1 % P-enriched diet (high dose, H), 
the third group (P-L28) was fed a 0.01 % P-enriched diet (low dose, L). The fourth group 
(P-H3) consisted of mice fed the standard diet without P for 25 days and for consequent 3 
days a 0.1% P-enriched diet (high dose, H). All groups were fed ad libitum. Body mass and 
food intake were monitored once a week. At the end of the experiment, all mice were 
fasted for 12 h and were sacrifi ced by cervical dislocation (all mice at the same day). Blood 
samples were collected into K3H-EDTA coated tubes; plasma and erythrocytes were sepa-
rated immediately by centrifugation (3000 rpm, 10 min, 10 °C). A er centrifugation and 
plasma removal, erythrocytes were washed three times with phosphate buff ered saline 
(PBS, pH = 7.4). Liver, small intestine and colon were removed, washed with PBS contain-
ing a protease inhibitor cocktail and immediately frozen in liquid nitrogen. All biological 
samples were stored in a freezer at –80 °C.
Analysis of oxidative stress parameters in blood
Selected parameters for evaluation of oxidative stress were determined using slight 
modifi cations of previously published methods: total level of SH groups (TSH) (9) and 
lipid peroxidation products such as malondialdehyde in plasma and in erythrocytes, GPx 
(10), CAT (11), GR (12), GST (13) and SOD (14) in red blood cells. All the parameters were 
expressed per grams of hemoglobin (Hb) in erythrocytes or total proteins in the case of 
plasma (15).
Preparation of subcellular fractions
Microsomal and cytosolic fractions were obtained from liquid nitrogen-frozen liver, 
small intestine and large intestine of mice. All tissues were individually homogenized in 
0.1 mol L–1 sodium phosphate buff er (pH 7.4) using a Po er-Elvehjem homogenizer (Bio-
tech International, UK). The subcellular fractions were isolated by diff erential centrifuga-
tion of the tissue homogenate. All fractions were stored at −80 °C. Protein concentrations 
in subcellular fractions were assayed using the bicinchoninic acid assay according to the 
general manufacturer’s protocol (Sigma-Aldrich).
Enzyme assays
Enzyme activities were assayed in the cytosolic and microsomal fractions from the 
homogenate of mouse liver, small intestine and large intestine. The enzyme activity assays 
(each performed in 4–8 replicates) were repeated three times. The amount of organic sol-
vents in the fi nal reaction mixtures did not exceed 1 % (V/V).
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Assays of all enzymes were based on spectrophotometric detection of the products 
formed or detection of decreasing substrate/cofactor levels using a microplate reader Tecan 
Infi nite M200 (Tecan, Switzerland) in cytosolic or microsomal fractions. Selected param-
eters for evaluation of oxidative stress were determined using slight modifi cations of pre-
viously published methods: cytosolic GST (13), peroxidase (Px) (16), GPx (17), catalase 
(CAT) (18), NQO (19), thioredoxin reductase (TrxR) and GR (20). The SOD assay was per-
formed using a SOD Assay kit-WST according to the general manufacturer’s protocol.
Statistical analysis
All calculations were done using Microso  Excel and GraphPad Prism 6.02 (GraphPad 
So ware, USA). One-way ANOVA was used for the statistical evaluation of the diff erences 
between the P-treated groups and the control. The diff erences were regarded as signifi cant 
when p < 0.05.
RESULTS AND DISCUSSION
The aim of the present in vivo study was to obtain detailed information about the ef-
fect of green tea catechins, in various dosage schemes, on oxidative stress status in mice. 
Commercially available Polyphenon, purifi ed form of green tea extract, was used in the 
study to simulate consumption of the traditional green tea beverage and/or green tea ex-
tract in dietary supplements.
Oral administration was chosen as it corresponds to the common way of catechin 
intake. Three tested dosage schemes represented three possible situations: regular con-
sumption of 2–3 cups of green tea daily (10 mg of catechins per kg of body mass, i.e., ap-
prox. 800 mg per person) and over-dose consumption of green tea extracts (100 mg of cat-
echins kg–1 bm, i.e., 8 g per person) in dietary supplements for a long (4 weeks) or short (3 
days) period. While approx. 300 mg of catechins were detected in one cup of green tea (21), 
one capsule of various dietary supplements may contain up to 1000 mg of green tea cate-
chins.
In our experiments, mice were chosen for this in vivo study as they are more similar 
to humans than rats in terms of catechin biotransformation (4). Seven-month-old mice 
served as the model of adult people who are more frequent users of natural dietary supple-
ments (including green tea extracts). Confl icting reports were found in the literature re-
garding the activity and/or expression of antioxidant enzymes during aging (reviewed in 
ref. 1). Age-related changes may vary among tissues and may not exhibit the same inten-
sity due to the biochemical activity of diff erent tissues and the presence of diff erent isoen-
zymes (1). Therefore, plasma, erythrocytes, liver, small intestine and large intestine were 
examined concurrently to obtain detailed information, since most of the previous studies 
on catechins’ eff ects were focused only on hepatic or plasmatic enzymes. Moreover, poor 
absorption of catechins results in their low systemic bioavailability a er oral administra-
tion but high intestinal and colonic mucosal exposure (22).
During all experiments, the body mass of mice and the amount of eaten pellets were 
monitored. The amount of eaten food per day was the same in all groups (4.9 ± 0.1 g per 
mouse). One mouse mass did not diff er among groups (44 ± 2 g).
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At the end of the experiment, blood, liver, small intestine and large intestine were 
removed from each animal. Each tissue served for the determination of the activity of 
several antioxidant enzymes.
Oxidative stress status of erythrocytes and plasma
In mouse erythrocytes, the amount of malondialdehyde and specifi c activities of the 
following antioxidant enzymes were assayed: CAT, GPx, GR, GST and SOD. Results are 
shown in Table I. Among tested parameters, specifi c activity of SOD was signifi cantly in-
creased in the P-H28 group but decreased in the P-H3 group compared to the control. In 
addition, specifi c activity of CAT was markedly elevated in P-H28 as well as in P-L28 
groups compared to the control. Other parameters did not signifi cantly diff er in P-treated 
mice when compared to the control.
In mouse plasma, the amount of SH-groups and concentration of malondialdehyde 
were assayed and the results are shown in Table II. In all P-treated groups, the amount of 
SH-groups was signifi cantly increased. P-treatment in all dosage schemes did not aff ect 
malondialdehyde concentration in plasma.
In our experiment, catechins of the green tea extract in all tested dosage schemes in-
creased signifi cantly the amount of SH-groups in mouse plasma. However, no activity of 
antioxidant enzymes (with the exception of SOD and CAT) was increased by P treatment. 
Due to these facts, it follows the P in all tested doses improved only mildly the oxidative 
Table I. Specifi c activities of antioxidant enzymes and malondialdehyde content (normalized to hemoglobin, 
Hb, concentration) in erythrocytes from control mice and mice treated with Polyphenon (P) at a high dose (H) 
and low dose (L) for 28 or 3 days
Controla P-H3a P-H28a P-L28a
Glutathione S-transferase (µkat g–1 Hb)   0.75 ± 0.10b 0.65 ± 0.13b 0.85 ± 0.11b 0.87 ± 0.19b
Glutathione peroxidase (µkat g–1 Hb) 10.4 ± 1.3b   9.4 ± 1.5b,c   8.3 ± 1.0b,c 13.6 ± 1.4b,d
Glutathione reductase (µkat g–1 Hb) 75.4 ± 3.2b 86.8 ± 15.9b 78.0 ± 15.3b 87.4 ± 11.8b
Superoxide dismutase (µkat g–1 Hb) 111.7 ± 3.7b 80.9 ± 7.9c 164.2 ± 9.3d 122.0 ± 10.4b
Catalase (µkat g–1 Hb)  6.0 ± 0.1b 5.7 ± 0.3b 6.8 ± 0.2c  6.8 ± 0.1c
Malondialdehyde (mmol g–1 Hb)  363 ± 56b 366 ± 68b 382 ± 35b 374 ± 72b
a Mean ± SD (n = 3).
b,c,d Groups with diff erent le ers vary signifi cantly (p ≤ 0.05).
Table II. Content of SH-group and malondialdehyde (normalized to protein concentration) in plasma from 
control mice and mice treated with Polyphenon (P) at a high dose (H) and low dose (L) for 28 or 3 days
Controla P-H3a P-H28a P-L28a
SH-group (µmol g–1 proteins) 67 ± 3b 100 ± 3c  81 ± 2d 112 ± 7e
Malondialdehyde (µmol g–1 proteins) 739 ± 99b 727 ± 20b 778 ± 61b   838 ± 11b
a Mean ± SD (n = 4).
b,c,d,e Groups with diff erent le ers vary signifi cantly (p ≤ 0.05).
70
H. Bártíková et al.: Eff ect of oral administration of green tea extract in various dosage schemes on oxidative stress status of mice in 
vivo, Acta Pharm. 65 (2015) 65–73.
 
stress status of mice. On the other hand, the oxidative stress in plasma and erythrocytes 
was not increased a er Polyphenon treatment. This indicates that green tea catechins, 
even at high doses, have no pro-oxidative eff ects in erythrocytes and plasma. In agreement 
with this fi nding, a lack of chronic toxicity of the catechin mixture up to 2.5 g kg–1 per day 
was documented in rats (23).
Antioxidant enzymes in liver, small intestine and large intestine
Activities of antioxidant enzymes CAT, SOD, GR, GPx, GST, NQO, peroxidase (Px) 
and thioredoxin reductase (TrxR) were assayed using specifi c substrates in cytosolic frac-
tions obtained from mouse liver, small intestine and large intestine. In all these tissues, the 
activities of all antioxidant enzymes were detectable. The results are summarized in Table 
III.
Table III. Specifi c activities of selected antioxidant enzymes in liver, small intestine and large intestine from 
control mice and mice treated with Polyphenon (P) at a high dose (H) and low dose (L) for 28 or 3 days
Enzyme Tissue Controla P-H3a P-H28a P-L28a
Peroxidase







  4.62 ± 1.07b
  1.25 ± 0.16b
  3.2 ± 0.7b 
  4.71 ± 0.31b
  0.97 ± 0.12b
  2.19 ± 0.74b
  3.99 ± 0.15b
  0.85 ± 0.23b
2.06 ± 0.6b
Glutathione peroxidase














 77.2 ± 5.2b,c
71.4 ± 2.5b
Catalase









  9.6 ± 0.6b
16.7 ± 3.5b
12.7 ± 3.0b
  8.3 ± 3.1b
18.8 ± 3.6b
11.0 ± 0.7b
  5.2 ± 2.2b
Superoxide dismutase















  19.1 ± 0.7b,c
Glutathione reductase















  11.7 ± 0.5b,c
Glutathione S-transferease











































 25.8 ± 1.7c
11.5 ± 0.9b
  9.3 ± 0.4b
  8.8 ± 2.6b
18.3 ± 1.0c
14.6 ± 1.2c
    9.1 ± 3.5b
a Mean ± SD (n = 3).
b,c,d,e Groups with diff erent le ers vary signifi cantly (p ≤ 0.05).
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Comparison of the obtained activities in P-treated mice and in controls revealed that 
P-treatment did not lead to a signifi cant increase in most antioxidant enzymes (with the 
exception of NQO, SOD and TrxR) in any tissue. Moreover, short-term P-treatment (P-H3 
group) caused a signifi cant decrease in hepatic SOD activity and intestinal GR activity. In 
the P-H28 group, activities of SOD (liver), GST (small intestine) and TrxR (small and large 
intestine) were signifi cantly decreased. Specifi c activity of TrxR was markedly reduced 
also in the large intestine of mice receiving low doses of P for 28 days.
Hepatic NQO activity was signifi cantly increased in the P-L28 group compared to the 
control. In small intestine, NQO was signifi cantly increased in P-L28 and P-H3 groups, 
while only short-term treatment (P-H3) led to NQO increase in large intestine.
In the P-L28 group, which simulates regular green tea consumption, NQO activity 
was signifi cantly increased in liver as well as in small intestine. As NQO converts qui-
nones to hydroquinones and reduces oxidative cycling, its increase is considered chemo-
preventive (24). Hence, elevation of NQO activity is probably benefi cial for green tea cat-
echins consumers. In mice from group P-H28, which represents a chronic overdose by 
dietary supplements with high content of green tea catechins, NQO, did not diff er from 
the controls. On the other hand, the catechin-enriched diet (0.2 %, m/m) administered to 
rats for 3 weeks lowered hepatic NQO activity by 26 % (7), but oral feeding of green tea 
catechins in drinking water (0.2 %, m/V) for 30 days raised signifi cantly the activities of 
NQO in mouse liver (25).
Short-term (3-days) overdose intake of green tea catechins (group P-H3) led to aug-
mentation of intestinal NQO activities, but hepatic SOD and intestinal GR activities were 
signifi cantly diminished. On the other hand, long-term (28-days) overdose consumption 
of green tea catechins (group P-H28) caused reduction in intestinal GST and TrxR activi-
ties. Decrease in GST activity could refl ect GST inhibition by catechins, which was ob-
served in vitro (26). These results warn that overdose consumption of catechins could sig-
nifi cantly decrease detoxifi cation of xenobiotics, especially in small intestine, with all the 
possible consequences.
Consistent with the fact that catechins are considered to be potential inducers of an-
tioxidant enzymes, an increase in some of them (NQO, TrxR and SOD) was observed in 
our study a er Polyphenon administration to mice. These results partly correspond with 
the conclusions of the previously published study that the catechin-enriched diet (0.2 %, 
m/m) administered for 3 weeks to rats did not aff ect the activity of hepatic CAT, GPx, GST 
and SOD (7). Conversely, oral feeding of a polyphenolic fraction isolated from green tea 
extract in drinking water (0.2 %, m/V) for 30 days elevated signifi cantly the activities of 
GPx, CAT, GR and GST in mouse small intestine and liver (26). Treatment of rats with a 1:1 
mixture of epicatechin and catechin (23 mg kg–1 bm, i.p. for 10 days) led to a signifi cant 
decrease in GPx activity and an increase in SOD activity in blood and urine (27) but the 
predictive value of this experimental set-up with intraperitoneal route of administration 
is questionable. Although catechins are generally believed to improve the oxidative stress 
status, analysis of the results of 31 controlled ex vivo and in vivo interventional studies in 
humans showed limited evidence that regular consumption of green tea (0.6–1.5 L per day) 
may increase antioxidant capacity and reduce lipid peroxidation (28).
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CONCLUSIONS
In conclusion, the increased content of SH-group in P-treated mice indicates the anti-
oxidant ability of catechins. No pro-oxidative eff ects of the green tea extract (in all tested 
dosage schemes) were observed in erythrocytes and plasma. P at low doses led to an in-
crease of NQO, SOD and TrxR activities, which may improve chemoprevention. On the 
other hand, P at high doses inhibits some antioxidant enzymes (SOD, GR, GST, TrxR). 
Based on these facts, consumption of catechins in reasonable amounts (i.e., regular drink-
ing of green tea) seems to be safe and benefi cial. On the other hand, consumption of ex-
tremely high doses of catechins in dietary supplements may disturb the oxidative balance 
via inhibition of certain antioxidant enzymes.
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